Drug Testing And Analysis 2012-01-01

A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.

Steven A Barker, Ethan H McIlhenny, Rick Strassman

文献索引：Drug Test. Anal. 4(7-8) , 617-35, (2012)

全文：HTML全文

摘要

Three indole alkaloids that possess differing degrees of psychotropic/psychedelic activity have been reported as endogenous substances in humans; N,N-dimethyltryptamine (DMT), 5-hydroxy-DMT (bufotenine, HDMT), and 5-methoxy-DMT (MDMT). We have undertaken a critical review of 69 published studies reporting the detection or detection and quantitation of these compounds in human body fluids. In reviewing this literature, we address the methods applied and the criteria used in the determination of the presence of DMT, MDMT, and HDMT. The review provides a historical perspective of the research conducted from 1955 to 2010, summarizing the findings for the individual compounds in blood, urine, and/or cerebrospinal fluid. A critique of the data is offered that addresses the strengths and weaknesses of the methods and approaches to date. The review also discusses the shortcomings of the existing data in light of more recent findings and how these may be overcome. Suggestions for the future directions of endogenous psychedelics research are offered.Copyright © 2012 John Wiley & Sons, Ltd.

相关化合物

  • N,N-二甲基色胺
  • 蟾蜍色胺

相关文献：

Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class.

2016-01-22

[Toxicol. Lett. 241 , 82-94, (2015)]

Biosynthesis of N,N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases.

2014-04-01

[Biochem. Pharmacol. 88(3) , 393-401, (2014)]

Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.

2012-01-01

[Drug Test. Anal. 4(7-8) , 610-6, (2012)]

Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.

2011-09-01

[Biomed. Chromatogr. 25(9) , 970-84, (2011)]

Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.

2009-12-01

[J. Neural Transm. Gen. Sect. 116(12) , 1591-9, (2009)]

更多文献...